Sareum Holdings (SAR LN)

Analysis

Health Care • United Kingdom

Sareum Holdings PLC is a clinical-stage small molecule company. The Company develops next-generation kinase inhibitors to treat auto immune diseases and cancer. Sareum Holdings serves customers in the United States.

Refresh

Focused

No publications yet

There aren’t any buy-side reports right now

Back to "All"

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00